OWKIN Inc. is a biotechnology company that specializes in applying artificial intelligence (AI) and machine learning (ML) to advance medical research. The company's mission is to discover new drugs, develop better treatments, and improve personalized medicine by leveraging data from leading academic medical centers and research institutions. OWKIN utilizes cutting-edge technology to analyze large, complex datasets, identifying hidden patterns that can lead to significant breakthroughs in understanding diseases and their treatments.OWKIN's platform integrates AI with medical expertise to foster collaborative research and innovation in the healthcare sector. Their solutions focus on oncology, cardiology, and other areas critical to advancing human health. Through partnerships with pharmaceutical companies, healthcare providers, and research organizations, OWKIN aims to transform how medical knowledge is generated and used for clinical practice.